These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 7562043

  • 21. Technetium-99m-MIBI scintimammography for suspicious breast lesions.
    Palmedo H, Schomburg A, Grünwald F, Mallmann P, Krebs D, Biersack HJ.
    J Nucl Med; 1996 Apr; 37(4):626-30. PubMed ID: 8691253
    [Abstract] [Full Text] [Related]

  • 22. Clinical utility of 99mTc-Sestamibi scintimammography in the management of equivocal breast lesions.
    De Cicco C, Trifirò G, Baio S, Sierra ML, Pizzamiglio M, Cassano E, Prisco G, Gatti G, Galimberti V, Luini A, Paganelli G.
    Cancer Biother Radiopharm; 2004 Oct; 19(5):621-6. PubMed ID: 15650455
    [Abstract] [Full Text] [Related]

  • 23. Is (99m)Tc-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses?
    Alonso O, Massardo T, Delgado LB, Horvath J, Kabasakal L, Llamas-Olier A, Maunda KK, Morales R, Padhy AK, Shankar UR.
    J Nucl Med; 2001 Nov; 42(11):1614-21. PubMed ID: 11696629
    [Abstract] [Full Text] [Related]

  • 24. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
    Lind P, Gallowitsch HJ, Kogler D, Kresnik E, Mikosch P, Gomez I.
    Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Prats E, Aisa F, Abós MD, Villavieja L, García-López F, Asenjo MJ, Razola P, Banzo J.
    J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
    [Abstract] [Full Text] [Related]

  • 29. International prospective evaluation of scintimammography with (99m)technetium sestamibi.
    Sampalis FS, Denis R, Picard D, Fleiszer D, Martin G, Nassif E, Sampalis JS.
    Am J Surg; 2003 Jun; 185(6):544-9. PubMed ID: 12781883
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
    Sun SS, Hsieh JF, Tsai SC, Ho YJ, Kao CH.
    Anticancer Res; 2000 Jun; 20(5C):3755-8. PubMed ID: 11268450
    [Abstract] [Full Text] [Related]

  • 32. The role of Tc99m-sestamibi scintimammography in combination with the triple assessment of primary breast cancer.
    Leidenius MH, Leppänen EA, Tykkä HT, von Smitten KA.
    Eur J Surg Oncol; 2002 Mar; 28(2):108-12. PubMed ID: 11884044
    [Abstract] [Full Text] [Related]

  • 33. Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions.
    Uriarte I, Carril JM, Quirce R, Gutiérrez-Mendiguchía C, Blanco I, Banzo I, Vega A, Hernández A.
    Eur J Nucl Med; 1998 May; 25(5):491-6. PubMed ID: 9575244
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison between 99mTc-sestamibi scintimammography and X-ray mammography in the characterization of clusters of microcalcifications: a prospective long-term study.
    Grosso M, Chiacchio S, Bianchi F, Traino C, Marini C, Cilotti A, Manca G, Volterrani D, Roncella M, Rampin L, Marzola MC, Rubello D, Mariani G.
    Anticancer Res; 2009 Oct; 29(10):4251-7. PubMed ID: 19846982
    [Abstract] [Full Text] [Related]

  • 36. Diagnostic value of 99mTc MIBI scintimammography in patients with breast lesions.
    Yildiz A, Colak T, Güngör F, Ozuğur S, Boz A, Tunçdemir F, Akaydin M.
    Rev Esp Med Nucl; 2001 Jun; 20(4):276-81. PubMed ID: 11440709
    [Abstract] [Full Text] [Related]

  • 37. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast.
    Rhodes DJ, O'Connor MK, Phillips SW, Smith RL, Collins DA.
    Mayo Clin Proc; 2005 Jan; 80(1):24-30. PubMed ID: 15667025
    [Abstract] [Full Text] [Related]

  • 38. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
    Fenlon HM, Phelan NC, O'Sullivan P, Tierney S, Gorey T, Ennis JT.
    Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
    [Abstract] [Full Text] [Related]

  • 39. 99mTc sestamibi scintimammography. Screening mammographic non-palpable suspicious breast lesions: preliminary results.
    Bekiş R, Derebek E, Balci P, Koçdor MA, Değirmenci B, Canda T, Durak H.
    Nuklearmedizin; 2004 Feb; 43(1):16-20. PubMed ID: 14978536
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
    Sommer H, Tiling R, Pechmann M, Kindermann G, Kress K, Moser R, Tatsch K, Hahn K, Pfluger T, Assemi C.
    Zentralbl Gynakol; 1997 Feb; 119(1):6-11. PubMed ID: 9050197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.